BioCentury
ARTICLE | Clinical News

Killed whole-cell Campylobacter vaccine: Began Phase I testing, under a CRADA with the U.S. Navy, in 20 volunteers, with 10 more volunteers as a control group

July 3, 1995 7:00 AM UTC

MicroCarb Inc. (CARB), Gaithersburg, Md. Product: Killed whole-cell Campylobacter vaccine Indication: Prevent gastroenteritis and diarrhea from Campylobacter infection Status: Began Phase I testing, ...